Related Experiment Video

Updated: Jul 24, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K

The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome

Kimberley Youkhana1, Hilary Heiling2, Allison Deal2

  • 1Division of Hematology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States.

TH Open : Companion Journal to Thrombosis and Haemostasis
|July 7, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

3.6K
Antibody Profiling by Luciferase Immunoprecipitation Systems LIPS
12:19

Antibody Profiling by Luciferase Immunoprecipitation Systems LIPS

Published on: October 7, 2009

27.1K

Related Experiment Videos

Last Updated: Jul 24, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K
Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

3.6K
Antibody Profiling by Luciferase Immunoprecipitation Systems LIPS
12:19

Antibody Profiling by Luciferase Immunoprecipitation Systems LIPS

Published on: October 7, 2009

27.1K

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

22
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
22
Rh Blood Group01:19

Rh Blood Group

1.6K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.6K

Articles linked to this work by shared authors, journal, and citation graph.

Re-evaluating absolute neutrophil count thresholds: Duffy-null-associated neutrophil count in cancer treatment.

BMJ case reports·2026

Management of inherited fibrinogen disorder during chemotherapy and allogeneic stem cell transplant.

BMJ case reports·2026

Thrombosis, Translational Medicine, and Biomarker Research: Moving the Needle.

Journal of the American Heart Association·2024

Livedoid vasculopathy in hemoglobinopathy-associated chronic leg ulcers.

Annals of hematology·2024

Impact of a Comprehensive Financial Navigation Intervention to Reduce Cancer-Related Financial Toxicity.

Journal of the National Comprehensive Cancer Network : JNCCN·2024

Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation Therapy.

Clinical breast cancer·2024

Clinical Event Rates and Patient Satisfaction with Generic Rivaroxaban in Atrial Fibrillation: The Prospective Guardian Study.

TH open : companion journal to thrombosis and haemostasis·2026

Plasma Level of Human Epididymis Protein 4 and Risk of Recurrence after First Venous Thromboembolism: The HUNT Study.

TH open : companion journal to thrombosis and haemostasis·2026

Prognostic Re-evaluation of Antinuclear Antibodies in Childhood Immune Thrombocytopenia.

TH open : companion journal to thrombosis and haemostasis·2026

Corrigendum: Efficacy and Safety of Avatrombopag Treatment in Immune Thrombocytopenia Patients in Poland: A Multicenter Study.

TH open : companion journal to thrombosis and haemostasis·2026

Microcytic or Iron Deficiency Anemia as a Risk Factor for Cerebral Sinus Venous Thrombosis-Systematic Review and Exploratory Meta-analysis.

TH open : companion journal to thrombosis and haemostasis·2026

Plasmin Generation Kinetics Reveal a Hyperfibrinolytic Phenotype in Patients with Pancreatic Ductal Adenocarcinoma.

TH open : companion journal to thrombosis and haemostasis·2026

Epitope-diverse autoantibodies induce neutrophil-epithelial niches driving kidney injury in ANCA-associated glomerulonephritis.

The Journal of experimental medicine·2026

Interpreting peripheral immune phenotypes in Parkinson's disease: an immune-context framework for biomarker qualification.

Reviews in the neurosciences·2026

Therapeutic Drug Monitoring of Golimumab to Predict Disease Activity and Antidrug Antibodies Status in Patients with Ankylosing Spondylitis.

Therapeutic drug monitoring·2026

Appropriateness of antiphospholipid antibody testing and its impact on diagnostic yield and clinical outcomes: a multicentre cohort study.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026

Tissue-specific inflammatory responses to systemic LPS in mice with LysM-lineage Hmgb1 deletion.

Brain, behavior, & immunity - health·2026

Beyond the Classic Triad: A Case of GQ1b Antibody-Positive Bickerstaff Brainstem Encephalitis Overlap Syndrome.

Cureus·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us